These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31035809)

  • 41. Assessing speech intelligibility of pathological speech in sentences and word lists: The contribution of phoneme-level measures.
    Xue W; van Hout R; Cucchiarini C; Strik H
    J Commun Disord; 2023; 102():106301. PubMed ID: 36709701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative assessment of interutterance stability: application to dysarthria.
    Cummins F; Lowit A; van Brenk F
    J Speech Lang Hear Res; 2014 Feb; 57(1):81-9. PubMed ID: 24687469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familiarization effects on word intelligibility in dysarthric speech.
    Kim H; Nanney S
    Folia Phoniatr Logop; 2014; 66(6):258-64. PubMed ID: 25676630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beyond Speech Intelligibility: Quantifying Behavioral and Perceived Listening Effort in Response to Dysarthric Speech.
    Fletcher AR; Wisler AA; Gruver ER; Borrie SA
    J Speech Lang Hear Res; 2022 Nov; 65(11):4060-4070. PubMed ID: 36198057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the Believability of Standardized Patients Trained to Portray Communication Disorders.
    Baylor C; Burns MI; Struijk J; Herron L; Mach H; Yorkston K
    Am J Speech Lang Pathol; 2017 Aug; 26(3):791-805. PubMed ID: 28595263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Comparative Study of Auditory-Perceptual Speech Measures for the Early Detection of Mild Speech Impairments.
    Kuruvilla-Dugdale M; Threlkeld K; Salazar M; Nolan G; Heidrick L
    Semin Speech Lang; 2019 Nov; 40(5):394-406. PubMed ID: 31426103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Face Masks and Speech Style on Speech Intelligibility and Listener Effort in Parkinson's Disease.
    Cline N; Knowles T; Badh G
    Am J Speech Lang Pathol; 2023 Sep; 32(5):2282-2296. PubMed ID: 37625133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Minimally Detectable Change of Speech Intelligibility in Speakers With Multiple Sclerosis and Parkinson's Disease.
    Stipancic KL; Tjaden K
    J Speech Lang Hear Res; 2022 May; 65(5):1858-1866. PubMed ID: 35442761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perception of intelligibility and qualities of non-native accented speakers.
    Fuse A; Navichkova Y; Alloggio K
    J Commun Disord; 2018; 71():37-51. PubMed ID: 29268109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease.
    Anand S; Stepp CE
    J Speech Lang Hear Res; 2015 Aug; 58(4):1134-44. PubMed ID: 26102242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation and cross-linguistic adaptation of the Frenchay Dysarthria Assessment (FDA-2) speech intelligibility tests: Hebrew version.
    Icht M; Bergerzon-Bitton O; Ben-David BM
    Int J Lang Commun Disord; 2022 Sep; 57(5):1023-1049. PubMed ID: 35714104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between objective measurement of the speech intelligibility of young people with dysarthria and listener ratings of ease of understanding.
    Landa S; Pennington L; Miller N; Robson S; Thompson V; Steen N
    Int J Speech Lang Pathol; 2014 Aug; 16(4):408-16. PubMed ID: 25011400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Speech Intelligibility in Dysarthrias: Influence of Utterance Length.
    Barreto SDS; Ortiz KZ
    Folia Phoniatr Logop; 2020; 72(3):202-210. PubMed ID: 31018200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of two sources of listener knowledge to intelligibility of speakers with cerebral palsy.
    Hustad KC
    J Speech Lang Hear Res; 2007 Oct; 50(5):1228-40. PubMed ID: 17905908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria.
    Hammen VL; Yorkston KM; Minifie FD
    J Speech Hear Res; 1994 Apr; 37(2):244-53. PubMed ID: 8028306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the Relationship between Speech Intelligibility and Fluency Indicators among English-Speaking Individuals with Parkinson's Diseases.
    Liu CT; Chu SW; Chen YS
    Behav Neurol; 2022; 2022():1224680. PubMed ID: 36225387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of level of presentation to listeners on scaled speech intelligibility of speakers with dysarthria.
    Kim Y; Kuo C
    Folia Phoniatr Logop; 2012; 64(1):26-33. PubMed ID: 21952405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Educational Information Improves Listener Attitudes Toward People With Dysarthria Secondary to Parkinson's Disease.
    Fletcher AR; Potts MW; Borrie SA
    Am J Speech Lang Pathol; 2023 May; 32(3):1099-1109. PubMed ID: 36881856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.